These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31803318)

  • 21. Phenobarbital and Phototherapy Combination Enhances Decline of Total Serum Bilirubin and May Decrease the Need for Blood Exchange Transfusion in Newborns with Isoimmune Hemolytic Disease.
    Kaabneh MA; Salama GS; Shakkoury AG; Al-Abdallah IM; Alshamari A; Halaseh RA
    Clin Med Insights Pediatr; 2015; 9():67-72. PubMed ID: 26309423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease.
    Mohan DR; Lu H; McClary J; Marasch J; Nock ML; Ryan RM
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
    Louis D; More K; Oberoi S; Shah PS
    Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy.
    Hammerman C; Kaplan M; Vreman HJ; Stevenson DK
    Biol Neonate; 1996; 70(2):69-74. PubMed ID: 8864425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin for hemolytic jaundice in Japan: A retrospective survey.
    Ono H; Kakiuchi S; Kusuda S
    Pediatr Int; 2023; 65(1):e15702. PubMed ID: 38037498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of Therapeutic Efficacy for Neonatal ABO Hemolytic Disease Treated with Intravenous Immunoglobin G by Different Modes of Administration].
    Liu YF; Zou CC; Yang HQ; Lou LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1842-1845. PubMed ID: 28024505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhesus isoimmunization: increased hemolysis during early infancy.
    Hayde M; Widness JA; Pollak A; Kohlhauser-Vollmuth C; Vreman HJ; Stevenson DK
    Pediatr Res; 1997 May; 41(5):716-21. PubMed ID: 9128296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double phototherapy in jaundiced term infants with hemolysis.
    Thaithumyanon P; Visutiratmanee C
    J Med Assoc Thai; 2002 Nov; 85(11):1176-81. PubMed ID: 12546314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia.
    Rasiah S; Jegathesan T; Campbell DM; Shah PS; Sgro MD
    Pediatr Res; 2023 Dec; 94(6):2092-2097. PubMed ID: 37491586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
    Slaughter JL; Kemper AR; Newman TB
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35927519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn].
    Cianciarullo MA; Ceccon ME; Vaz Fv
    Rev Assoc Med Bras (1992); 2003; 49(1):45-53. PubMed ID: 12724812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulins in rhesus hemolytic disease.
    Mukhopadhyay K; Murki S; Narang A; Dutta S
    Indian J Pediatr; 2003 Sep; 70(9):697-9. PubMed ID: 14620183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
    Singhal PK; Singh M; Paul VK; Deorari AK; Ghorpade MG
    Indian Pediatr; 1992 Mar; 29(3):319-25. PubMed ID: 1612673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
    Keir AK; Dunn M; Callum J
    J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
    Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
    Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.